Entrada Therapeutics, Inc. · NASDAQ:TRDA

Wentworth Kory James had 1,733 Entrada Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Sep 2, 2026 · Filed Sep 3, 2026

On Sep 2, 2026, Wentworth Kory James (Chief Financial Officer) had 1,733 Entrada Therapeutics, Inc. shares withheld for tax at US$7.14 for US$12,374, leaving 117,277 shares. Filed Sep 3, 2026 (Form 4).

Withheld for tax
1,733 shares
Price
US$7.14
Value
US$12,374
Holding after
117,277 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026Common StockShares withheld for tax1,733US$7.14117,277Direct

Source

View original at SEC

Related